巴曲酶通过增强血流促进烧伤创面愈合
该研究在小鼠全层烧伤模型中每日腹腔注射巴曲酶(30 BU/kg),发现其可阻止烧伤创面进展并加速愈合,机制涉及增强血流、减少TNF-α和NOX2表达、降低HIF-1α合成、增加S100A4+成纤维细胞聚集及生长因子产生。
要点
- 小鼠全层烧伤后每日腹腔注射巴曲酶30 BU/kg可阻止创面进展。
- 巴曲酶增强血流、增加S100A4+成纤维细胞聚集并促进生长因子产生。
- 巴曲酶降低TNF-α、NOX2表达及HIF-1α合成。
核心结论
- 全身给予巴曲酶可阻止烧伤创面进展并通过增强血流加速愈合过程。
研究设计与样本
- 在C57BL/6小鼠背部以90°C、直径5 mm烙铁接触10秒制作全层烧伤创面。
- 致伤后立即每日腹腔注射巴曲酶30 BU/kg,对照组注射等体积生理盐水。
- 分析创面面积、组织学、血流、生长因子与趋化因子合成及缺血再灌注相关因子表达。
主要发现
- 巴曲酶全身给药阻止了烧伤创面进展,伴随肿瘤坏死因子-α和NOX2表达降低及缺氧诱导因子-1α合成减少。
- 巴曲酶通过增强血流、增加S100A4+成纤维细胞聚集并刺激碱性成纤维细胞生长因子、表皮生长因子和胎盘生长因子产生促进愈合。
- 巴曲酶加速血管生成和S100A4阳性成纤维细胞聚集,伴随局部碱性成纤维细胞生长因子产生增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the process of burn wound healing, promoting healing and suppressing wound progression by enhancing blood flow is considered essential. Various agents that increase blood flow are currently being assessed. Batroxobin (DF-521; Defibrase) is a defibrinogenating agent extracted from Bothrops moojeni , used as a thrombin-like serine protease to improve ischemic conditions. However, it remains unclear how this agent affects the burn wound healing process. In this study, the authors conducted analyses to define the effects of batroxobin administration on burn wound healing. METHODS: Full-thickness burn wounds were created on the dorsal skin of C57BL/6 mice by applying a 90°C, 5-mm-diameter soldering iron for 10 seconds. Immediately after wounding, batroxobin (30 batroxobin units/kg per mouse) was administered intraperitoneally daily. As a vehicle control, the same volume of saline was administered. The authors analyzed wound area, histologic findings, blood flow, growth factor and chemokine synthesis, and factor expression related to ischemia-reperfusion. RESULTS: The authors found that the systemic administration of batroxobin prevented burn wound progression, which was accompanied by decreased expression of tumor necrosis factor-α and NOX2 and reduced synthesis of hypoxia-inducible factor-1α. In addition, this agent promoted wound healing by enhancing blood flow, increasing S100A4 + fibroblast accumulation, and stimulating the production of growth factors (basic fibroblast growth factor, epidermal growth factor, and placental growth factor). CONCLUSIONS: These results indicate that the systemic administration of batroxobin prevented burn wound progression and accelerated the healing process by enhancing blood flow. CLINICAL RELEVANCE STATEMENT: The authors demonstrated that the treatment of batroxobin accelerated angiogenesis and S100A4-positive fibroblast accumulation, accompanied by increased local basic fibroblast growth factor production. In addition, batroxobin was found to reduce burn wound progression.
引用
- Imai T, Sato Y, Tanno H, et al. Batroxobin Promotes Wound Healing after Burn Injury by Enhancing Blood Flow. Plast Reconstr Surg. 2025. PMID: 40178840. doi:10.1097/PRS.0000000000012137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。